Patent Assignment
Reel/Frame 062813/0382
Change of Name
Recorded: 2023-02-21
Pages: 6
Assignor
ESKER THERAPEUTICS, INC.
Executed: 2022-01-06
Assignee
ALUMIS INC.
611 GATEWAY BOULEVARD, SUITE 820, SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
Substituted 1,2,4-Triazoles as Intermediates in the Syntheisis of TYK2 Inhibitors
Substituted 1,2,4-Triazoles as Intermediates in the Synthesis of TYK2 Inhibitors
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.